0001193125-15-028037 Sample Contracts

Dated 21 June 2013 Lease between MEPC Milton Park No. 1 Limited and MEPC Milton Park No. 2 Limited and Summit Corporation plc relating to 85b Park Drive Milton Park

Summit Corp PLC • January 30th, 2015 • Pharmaceutical preparations

• Company
  Summit Corp PLC
• Filed
  January 30th, 2015
• Industry
  Pharmaceutical preparations

OPTION AGREEMENT

Option Agreement • January 30th, 2015 • Summit Corp PLC • Pharmaceutical preparations • England and Wales

• Contract Type
  Option Agreement
• Filed
  January 30th, 2015
• Company
  Summit Corp PLC
• Industry
  Pharmaceutical preparations
• Jurisdiction
  England and Wales

MDA Venture Philanthropy Grant Contract Between Muscular Dystrophy Association, Inc. and Summit Corporation plc (for the development of DMD and/or BMD therapeutics)

Reviewer Confidentiality Agreement • January 30th, 2015 • Summit Corp PLC • Pharmaceutical preparations • New York

• Contract Type
  Reviewer Confidentiality Agreement
• Filed
  January 30th, 2015
• Company
  Summit Corp PLC
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This MDA Venture Philanthropy Corporate Grant Contract (“Contract”) is entered into as of December 15, 2011 (the “Effective Date”), between Muscular Dystrophy Association, Inc., a New York not-for-profit corporation (“MDA”) and Summit Corporation plc, a company incorporated in England and listed on the Alternative Investment Market of the London Stock Exchange having its registered office at 91 Milton Park, Abingdon, Oxfordshire, OX14 4RY, England (“GRANTEE”), to document the terms upon which MDA will provide funding for the Project (as defined below) and certain related matters. MDA and GRANTEE are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”

Grant Agreement Between Duchenne Partners Fund, and Summit Corporation plc (for the development of DMD and or BMD therapeutics)

Confidentiality Agreement • January 30th, 2015 • Summit Corp PLC • Pharmaceutical preparations • New York

• Contract Type
  Confidentiality Agreement
• Filed
  January 30th, 2015
• Company
  Summit Corp PLC
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This Contract (“Contract”) is entered into as of 15th December, 2011, between Duchenne Partners Fund, Inc., a Delaware limited liability company (“DPF”), and Summit Corporation plc, a company incorporated in England and listed on the Alternative Investment Market of the London Stock Exchange having its registered office at 91 Milton Park, Abingdon, Oxfordshire, OX14 4RY, England (“GRANTEE”), to document the terms upon which DPF will provide funding for the Project (as defined below) and certain related matters. DPF and GRANTEE are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”